THE USE OF UNRELATED BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA

被引:0
作者
BEATTY, PG
机构
[1] Bone Marrow Transplant Program, University of Utah School of Medicine, Salt Lake City
来源
TRANSFUSION SCIENCE | 1991年 / 12卷 / 03期
关键词
D O I
10.1016/0955-3886(91)90117-L
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although marrow transplantation is the treatment of choice for chronic myelogenous leukemia, its full application is limited by donor availability. It now appears that the use of volunteer unrelated donors wil be feasible and efficacious, albeit with a higher likelihood of complications. Thus, marrow grafting from unrelated donors should be considered in most instances where transplantation from a matched sibling would be contemplated.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 18 条
[1]  
Martin, Najfeld, Hansen, Et al., Involvement of the B-lymphoid system in chronic myelogenous leukemia, Nature, 287, (1980)
[2]  
Nowell, Hungerford, A minute chromosome in human chronic granulocytic leukemia, Science, 132, (1960)
[3]  
Rowley, A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining, Nature, 243, (1973)
[4]  
Sokal, Cox, Baccarani, Et al., Prognostic discrimination in “good-risk” chronic granulocytic leukemia, Blood, 63, (1984)
[5]  
Talpaz, Kantarjian, Trujillo, Et al., Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia, N Engl J Med, 314, (1986)
[6]  
Fefer, Cheever, Greenberg, Et al., Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins, N Engl J Med, 306, (1982)
[7]  
Thomas, Clift, Fefer, Et al., Marrow transplantation for the treatment of chronic myelogenous leukemia, Ann Intern Med, 104, (1986)
[8]  
Goldman, Apperley, Jones, Bone marrow transplantation for patients with chronic myeloid leukemia, N Engl J Med, 314, (1986)
[9]  
Goldman, Gale, Horowitz, Et al., Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion, Ann Intern Med, 108, (1988)
[10]  
Storb, Deeg, Whitehead, Et al., Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia, N Engl J Med, 314, (1986)